Internal Medicine · Mooresville, NC
NPI
1700197647
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
128 Medical Park Rd Ste 101
Mooresville, NC, 28117
Phone (704) 658-1001
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
150,000 services
Medicare patients, 2024
486
Average age 74
Drug cost, 2024
$3.3M
4,857 prescriptions
Company payments, 2025
$67.79
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dijana T Christianson was code J3262 (injection, tocilizumab, 1 mg), 50,120 times for 12 patients. In total Dijana T Christianson billed 150,000 services in 98 codes, and Medicare paid $1.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 50,120 | 12 | $4.71 | $236K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 40,400 | 13 | $3.60 | $146K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 17,600 | 32 | $33.91 | $597K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 9,200 | 12 | $9.11 | $84K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 8,670 | 25 | $24.34 | $211K |
| J0897 Injection, denosumab, 1 mg | Office | 7,680 | 96 | $20.63 | $158K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,340 | 37 | $0.10 | $241 |
| 99214 Office E&M - Established | Office | 1,073 | 344 | $89.63 | $96K |
| 36415 Venipuncture Blood Collection | Office | 875 | 341 | $8.56 | $7,493 |
| 86140 Clinical Chemistry | Office | 842 | 336 | $4.96 | $4,179 |
| 80053 Clinical Chemistry | Office | 835 | 337 | $10.09 | $8,428 |
| 85652 Clinical Chemistry | Office | 834 | 328 | $2.62 | $2,181 |
| 85025 Blood Count | Office | 803 | 308 | $7.41 | $5,954 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 606 | 84 | $0.51 | $308 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 568 | 273 | $11.95 | $6,789 |
By year: 2022 $1.6M for 131,618 services; 2023 $1.7M for 136,112 services; 2024 $1.8M for 150,000 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 875 | 341 | $8.56 | $7,493 |
| 86140 Clinical Chemistry | 842 | 336 | $4.96 | $4,179 |
| 80053 Clinical Chemistry | 835 | 337 | $10.09 | $8,428 |
| 85652 Clinical Chemistry | 834 | 328 | $2.62 | $2,181 |
| 85025 Blood Count | 803 | 308 | $7.41 | $5,954 |
| 86160 Immunoassay | 224 | 66 | $11.13 | $2,493 |
| 84550 Clinical Chemistry | 109 | 87 | $4.35 | $474 |
| 82784 Immunoassay | 75 | 23 | $9.11 | $684 |
| 86431 Immunoassay | 66 | 66 | $5.48 | $361 |
| 82550 Clinical Chemistry | 35 | 32 | $6.38 | $223 |
Medicare prescription drug claims, 2024
In 2024, the drug Dijana T Christianson prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,013 prescriptions and refills. In total Dijana T Christianson wrote 4,857 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,013 | 2,238 | 293 | $33K |
| Methotrexate Methotrexate Sodium | 346 | 798 | 102 | $8,013 |
| Prednisone Generic | 341 | 483 | 166 | $2,093 |
| Gabapentin Generic | 234 | 419 | 66 | $2,899 |
| Tramadol Hcl Generic | 204 | 204 | 39 | $1,595 |
| Leflunomide Generic | 179 | 337 | 45 | $9,733 |
| Cyclobenzaprine Hcl Generic | 159 | 213 | 37 | $1,161 |
| Sulfasalazine Dr Sulfasalazine | 141 | 230 | 39 | $5,028 |
| Duloxetine Hcl Generic | 137 | 299 | 36 | $2,210 |
| Pregabalin Generic | 126 | 186 | 25 | $3,457 |
| Colchicine Generic | 120 | 204 | 40 | $6,871 |
| Allopurinol Generic | 118 | 339 | 35 | $1,224 |
| Celecoxib Generic | 110 | 193 | 28 | $1,975 |
| Tizanidine Hcl Generic | 103 | 191 | 39 | $720 |
| Meloxicam Generic | 98 | 120 | 21 | $228 |
Brand drugs: 692 claims; generic drugs: 4,153 claims; opioid claims: 342.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dijana T Christianson $67.79 ($67.79 in general payments such as food, travel and fees) from 3 companies. The largest payer was Janssen Biotech, Inc. with $29.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.